Best Life Sciences Companies in Oregon, United States
The 143 best Life Sciences companies in Oregon, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Quantrx.com.
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Oregon
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Quantrx.com Developer and commercializer of diagnostic products for the healthcare industry | $416M | 202 mo ago | Public | 10 | Michael Hogan Founder | — | — | — |
| 2 | Aronora Developing first-in-class biologics for life-threatening blood diseases with unmet needs | $55M | 10 mo ago | Seed | 8 | Erik Tucker President & CEO | — | 45 patents Antibody-based anticoagulant therapeutics targeting coagulation factors XI, XII, thrombin, and thrombopoietin. | — |
| 3 | Chembio POC Diagnostics for Infectious Diseases using a proprietary immunoassay platform 60Funding top 23%Product top 32%Innovation top 38%Moat top 39% All 9 signals ▾Fundingtop 23% Producttop 32% Innovationtop 38% Moattop 39% Markettop 41% Fin. healthtop 45% Growthtop 48% Techtop 50% Globalbottom 32% Funding: Raised $33.7M across 7 rounds · 7 rounds over 7 yrs (1.0/yr) Product: 3 distinct product lines · Company stage: Acquired rank vs industry peers · Fliar Intelligence Index 60/100 | $34M | 4 mo ago | Acquired | 337 | — | WordPressMySQLPHP+27 | — | 3 launchs |
| 4 | Kiyatec Develops 3D phenotypic cell-based assays and diagnostic solutions for prediction of patients’ response to… 32Product top 25%Moat top 32%Funding top 37%Innovation top 48% All 9 signals ▾Producttop 25% Moattop 32% Fundingtop 37% Innovationtop 48% Patentstop 50% Marketbottom 40% Globalbottom 37% Techbottom 36% Newsbottom 21% Product: 5 distinct product lines · Company stage: Series C Moat: Editorial + unicorn rating 7/10 · IP moat: 36 patents rank vs industry peers · Fliar Intelligence Index 32/100 | $29M | 7 mo ago | Series C | 28 | — | — | 36 patents In vitro cancer drug screening platforms using 3D tumor bioreactors for dosing optimization | — |
| 5 | Phylos Bioscience Developer of cannabis F1 hybrid seeds and natural THC products 42Funding top 26%Moat top 39%Talent top 41%Partners top 45% All 9 signals ▾Fundingtop 26% Moattop 39% Talenttop 41% Partnerstop 45% Techtop 46% Marketbottom 46% Growthbottom 38% Globalbottom 37% Newsbottom 17% Funding: Raised $28.2M across 10 rounds · 10 rounds over 11 yrs (0.9/yr) Moat: Editorial + unicorn rating 7/10 · 9 curated direct competitors tracked rank vs industry peers · Fliar Intelligence Index 42/100 | $28M | 5 mo ago | Series B | 61 61 → 50 (-18%) | Nishan Karassik Chief Innovation Officer | PrismicNode.jsNginx+14 | — | 4 launchs |
| 6 | Inovise Medical Developer of diagnostic medical technology for cardiac care | $28M | 165 mo ago | Series B | 9 | — | — | — | — |
| 7 | Najit Technologies Developing safe, effective vaccines against infectious diseases of global importance | $26M | 16 mo ago | Funding Raised | — | Mark Slifka President & CEO | — | 5 patents Patents concentrated in health & consumer products | — |
| 8 | Tricol Biomedical Hemostasis and wound-care innovator dedicated to saving lives | $26M | 56 mo ago | Funding Raised | 24 | Kz Hong President and CEO | WordPressMySQLPHP+28 | 48 patents Chitosan-based hemostatic and tissue‑adhesive medical devices for surgical bleeding control | — |
| 9 | MolecularMD Provider of molecular diagnostics for oncology applications | $16M | 112 mo ago | Acquired | 83 | — | — | 2 patents Patents concentrated in computing, sensing & instrumentation | — |
| 10 | VisCardia Developer of implantable medical therapy for the treatment of heart failure | $16M | 8 mo ago | Series C | 5 | — | — | 70 patents Implantable diaphragmatic stimulation systems for cardiac and respiratory therapeutic support | — |
| 11 | Kannact Human-driven digital health company providing personalized support for chronic condition management | $14M | 124 mo ago | Series A | 36 | — | SanityNode.jsReact+11 | — | — |
| 12 | Electrical Geodesics Non-invasive neurodiagnostic imaging products are built upon a dense array of EEG technology platforms | $13M | 125 mo ago | Acquired | 87 | Don Tucker Co-Founder & CEO | JoomlaPHPYouTube+12 | 15 patents Patents concentrated in health & consumer products | — |
| 13 | Virogenomics Bridging the gap between early-stage technology and marketplace success | $11M | 24 mo ago | Series A | — | Jeff King CEO | — | 6 patents Patents concentrated in chemistry & materials | — |
| 14 | DiabetOmics Point-of-care risk assessment tests for diabetes and womens health disorders. | $11M | 135 mo ago | Series C | 3 | — | WordPress Block EditorWordPressMySQL+12 | 41 patents Patents concentrated in computing, sensing & instrumentation | — |
| 15 | Veana Therapeutics Developing alpha-tocopheryloxyacetic acid (Alpha-TEA, a vitamin E analog) cancer immunotherapy technologies | $10M | 58 mo ago | Seed | 4 | — | — | — | — |
| 16 | BioSpeech Biomedical applications of speech technology for better hearing and communication | $9M | 81 mo ago | Funding Raised | 9 | Jan Santen Founder | — | — | — |
| 17 | Sofwave Enterprises Non-invasive aesthetic solutions for skin regeneration, lifting, and muscle toning | $8M | 82 mo ago | Public | 122 | Louis Scafuri CEO | Apple iCloud MailMicrosoft 365Zoho+10 | — | 2 partnerships · 1 award |
| 18 | TriAgenics Developer of a minimally invasive wisdom tooth prevention treatment. | $8M | 14 mo ago | Series A | 2 | Leigh Colby CEO & President | WordPressMySQLPHP+16 | 91 patents Dental therapeutic ablation devices for targeted tooth‑bud removal and related medical probe systems. | — |
| 19 | Elex biotech Developing innovative therapies for arrhythmias and heart failure | $8M | 120 mo ago | Funding Raised | 7 | Sandra Shotwell Co-Founder | — | — | — |
| 20 | INVO Bioscience A medical device company specializing in fertility solutions | $7M | 39 mo ago | Public | 15 15 → 18 (+20%) | Katie Karloff CEO | WordPressMySQLPHP+24 | — | — |
| 21 | Gobiquity Pediatric vision and hearing screening solutions on a mobile digital platform | $7M | 117 mo ago | Series B | 13 | — | — | 8 patents Digital photorefraction and acuity testing for pediatric eye screening and retinal monitoring | 2 launchs |
| 22 | TomegaVax Developing cytomegalovirus-vector based vaccines for viral infections | $7M | 111 mo ago | Acqui-Hired | — | Michael Tippie CEO | — | — | — |
| 23 | Hemex Health Portable diagnostic devices empowering healthcare frontlines with affordable, accurate testing | $6M | 21 mo ago | Series A | 26 | — | Cart FunctionalitySquarespace CommerceSquarespace+23 | 89 patents Point‑of‑care diagnostic devices using electrophoresis, sonication and enhanced imaging for health assays | 1 partnership |
| 24 | Convergent Genomics Genomic diagnostics company transforming urologic cancer care through innovative technology | $6M | 117 mo ago | Funding Raised | 24 | Trevor Levin Founder and Chief Scientific Officer | — | 24 patents Patents concentrated in chemistry & materials | — |
| 25 | Brain Electrophysiology Laboratory Provider of neuroscience technologies for sleep management | $5M | 45 mo ago | Funding Raised | 18 | — | — | 13 patents Patents concentrated in health & consumer products | — |
| 26 | Chemica technologies Specializes in drug delivery, separations technologies and custom synthesis of bioactive compounds | $5M | 73 mo ago | Funding Raised | — | — | — | — | — |
| 27 | Precision Biomonitoring Provider of molecular diagnostic solutions for the detection of organisms | $5M | 72 mo ago | Acquired | 28 | Mario Thomas Ddsa Dir Co-Founder | — | — | — |
| 28 | DesignMedix Life science & diagnostic supply: reagents, antibodies, kits, instruments, and services | $5M | 110 mo ago | Series A | 6 | — | — | 7 patents Patents concentrated in chemistry & materials | — |
| 29 | Ceek Womens Health Innovative women's health solutions for comfortable gynecological exams and procedures | $5M | 16 mo ago | Series B | 26 | Fahti Khosrowshahi Founder & CEO | Cart FunctionalityShopifyShop Pay+17 | — | 4 launchs |
| 30 | Rare Air Health Provider of precision pulmonary drug delivery platform | $5M | 6 mo ago | Series A | — | Kirk Gerner CEO | Founder | — | — | — |
| 31 | ZIPLYFT Provider of a minimally invasive surgery solution for blepharoplasty procedure | $5M | 5 mo ago | Seed | — | Patricia Buehler Co-Founder & CEO | WebflowWordPressMySQL+13 | — | 1 partnership |
| 32 | dātma Provider of software to clinics for decision-making and omics data automation | $5M | 18 mo ago | Seed | 46 | Christopher Corless Co-Founder | — | — | — |
| 33 | Sonivate Innovative ultrasound technology company revolutionizing medical imaging with portable, easy-to-use devices | $4M | 79 mo ago | Series A | 7 | — | — | — | — |
| 34 | Madorra Provider of a therapeutic device for the treatment of vaginal atrophy and dryness | $4M | 21 mo ago | Series A | 6 | Holly Rockweiler Co-Founder & CEO | — | 22 patents Medical ultrasound systems for vulvovaginal aesthetic rejuvenation procedures | — |
| 35 | Gamma Therapeutics Developer of therapeutic devices for cardiovascular disorders | $4M | 33 mo ago | Funding Raised | 4 | David Farrell Founder & Chief Scientific Officer | — | — | — |
| 36 | Vaginal Biome Science Developer of microbiome-based therapies focused on women’s vaginal health | $3M | 47 mo ago | Seed | — | Wendy Strgar Founder & CEO | — | — | — |
| 37 | InVivo Biosystems Provider of animal models for in-vivo analytical services | $3M | 15 mo ago | Series A | 62 | Matt Beaudet Co-Founder | WordPressMySQLPHP+25 | — | — |
| 38 | Wile Provider of personalized supplements based on the quiz | $3M | 49 mo ago | Acquired | 7 | — | Cart FunctionalityShopifyShop Pay+36 | — | — |
| 39 | Haystack Robotics Provider of robotic solutions for disinfection of indoor spaces | $3M | 24 mo ago | Seed | — | Mahadev Eakambaram CEO | WordPressMySQLPHP+23 | — | — |
| 40 | Ubivac Developer of dendritic cell (DC)-targeted complex vaccine combination immunotherapy for cancer | $3M | 17 mo ago | Seed | 5 | — | — | 23 patents Patents concentrated in chemistry & materials | — |
| 41 | Cascade Prodrug Developing targeted oncology therapy activating prodrugs selectively within solid tumors | $2M | 74 mo ago | Seed | 3 | August Sick Co-Founder | — | 7 patents Patents concentrated in health & consumer products | — |
| 42 | PDX Pharmaceuticals Nanomaterials for cancer (breast, prostate, and pancreatic cancers), fibrosis, and hyperphosphatemia | $2M | 21 mo ago | Seed | 9 | Wassana Yantasee CEO & President | — | — | 1 launch |
| 43 | Pacific Diabetes Technologies Innovative diabetes management solutions through a single, integrated device | $2M | 8 mo ago | Series A | 15 | Robert S. Cargill CEO & President | — | 40 patents Integrated closed-loop insulin delivery and continuous glucose monitoring via trocarless biosensor cannula. | — |
| 44 | NeuraMedica Developer of a dural clip that helps in durotomy and orthopedic spinal closures | $1M | 35 mo ago | Seed | 5 | Neil Roundy Co-Founder | — | 7 patents Patents concentrated in health & consumer products | — |
| 45 | BaroPace Developer of smart wearable devices for cardiac health monitoring | $940K | 21 mo ago | Seed | 3 | Michael Burnam Founder & CEO | — | 71 patents Adaptive cardiac pacemakers that adjust pacing based on physiological biomarkers and vascular resistance | — |
| 46 | Axia Orthopedics Developer of medical devices intended to offer a fracture reduction system | $842K | 18 mo ago | Seed | — | Andy Seykora Co-Founder & CEO | — | — | 4 launchs |
| 47 | TheraFluor Developer of photosensitive dyes and instrument platform for fluorescence-guided cancer surgery | $810K | 13 mo ago | Funding Raised | — | August Sick CEO | — | — | — |
| 48 | EnterX Operator of a biotechnology company delivering genetic medicine through cell-specific delivery | $588K | 27 mo ago | Funding Raised | — | Kevin Love Co-Founder | — | — | — |
| 49 | ProMedix Provider of home base device for health monitoring and emergency or critical care | $560K | 33 mo ago | Seed | 66 | David Sheridan Co-Founder & CEO | — | 8 patents Non-invasive capillary refill time measurement devices for clinical vital sign monitoring | — |
| 50 | Trace Biosciences Provider of imaging agents for surgery | $386K | 13 mo ago | Funding Raised | 5 | — | — | — | 1 internship |
Top 12 Life Sciences companies in Oregon
#1
Acquired · Medford, Oregon · founded 1986 · 337 employees$33.7Mraised▾
Chembio Diagnostics, Inc. specializes in proprietary rapid diagnostic tests. Chembio's two FDA PMA-approved, CLIA-waived, rapid HIV tests are marketed in the U.S. by Alere, Inc. Chembio markets its HIV STAT-PAK® line of rapid HIV tests internationally to government and donor-funded programs directly and through distributors. Chembio has developed a patented point-of-care test platform technology, the Dual Path Platform (DPP®) - a chromatographic immunoassay technology, which the company claims offers offers significant advantages over Lateral Flow (LF) technology.
- Feb 2026Grant (prize money)$1.8M
- Sep 2019Conventional Debt$20M
- Feb 2011Grant (prize money)—
- Feb 2011Grant (prize money)$2.8M
#2
Series B · Portland, Oregon · founded 2014 · 61 employees$28.2Mraised▾
Developer of cannabis F1 hybrid seeds and natural THC products. The company empowers growers to produce high-quality cannabis cost-effectively. It offers elite, phenotypically-stable, fully-feminized true F1 hybrid seed lines. The company's seed-grown plants rival the uniformity of clonal varieties for harvest height, wet biomass, and total THC. It provides insights on mitigating HLVd risk with F1 hybrid production-ready seeds.
- Dec 2025Series B$3M
- Dec 2025Series B$583.4K
- Oct 2024Series B$1.8M
- Nov 2023Series B$150K
#3
Series C · Pendleton, Oregon · founded 2005 · 28 employees$29.5Mraised▾
Kiyatec specializes in developing solutions for the prediction of patient's response to cancer drug treatment, with a focus on data correlation to human clinical outcomes. It develops live phenotypic 3D cell-based models for drug response profiling and applies them to generate information relevant to preclinical testing, clinical trials, and clinical diagnostics applications. This information helps in drug selection, minimizing clinical trials failures, and maximizing patient outcomes in the clinic.
- Nov 2025Series C—
- Oct 2024Series C$250K
- May 2023Series C—
- Dec 2022Series C$18.1M
#4
Seed · Portland, Oregon · founded 2009 · 8 employees$54.8Mraised▾
Developing first-in-class biologics for life-threatening blood diseases with unmet needs. The company is a clinical-stage biopharmaceutical company focused on developing and commercializing novel medicines for blood diseases. They are committed to bringing innovative therapies to patients. Their pipeline targets disease-modifying pathways with unique mechanisms of action. They are developing safe, paradigm-shifting drugs. Their research and development efforts focus on areas such as anticoagulation, thrombosis prevention, and inflammation reduction. They are working towards creating a positive social impact by addressing significant unmet medical needs in hematology. They are developing biologics and novel therapeutics.
- Aug 2025Grant (prize money)$5.5M
- Feb 2025Grant (prize money)$3.8M
- Jun 2024Grant (prize money)$494K
- Oct 2023Seed—
#5
Series C · Beaverton, Oregon · founded 2015 · 5 employees$15.8Mraised▾
Developer of implantable medical therapy for the treatment of heart failure. The product VisONE delivers Synchronized Diaphragmatic Stimulation therapy it modulates intrathoracic pressure pulses on the cardiovascular system and relieves symptoms resulting from hemodynamic insufficiency.
- Oct 2025Series C$9.5M
- Mar 2022Series B$10.8M
- Apr 2021Series B$200K
- Jan 2019Series B$400K
#6
Seed · Bend, Oregon · founded 2020$4.7Mraised▾
Provider of a minimally invasive surgery solution for blepharoplasty procedure. It offers a device for eyelid surgery for both patients and surgeons. It allows the surgeon to see the skin markings of the tissue to be remove for blepharoplasty operations.
- Jan 2026Seed$250K
- Jul 2024Seed$4.7M
#7
Series A · Corvallis, Oregon · founded 2021$4.7Mraised▾
Provider of precision pulmonary drug delivery platform. The company's proprietary Microfluidic Aerosolization Platform that brings aerosolized gene therapy for the treatment of advanced lung diseases.
- Dec 2025Series A$4.7M
#8
Funding Raised · Beaverton, Oregon · founded 2004$26.2Mraised▾
Developing safe, effective vaccines against infectious diseases of global importance. The company is dedicated to creating vaccines for underserved and vulnerable populations, focusing on emerging and re-emerging infectious diseases. Their strategy involves a vaccine platform designed for increased safety and immunogenicity. Core values include scientific innovation, teamwork, and a commitment to global well-being. They develop vaccines for both endemic and newly emerging diseases affecting millions worldwide. The company donates a percentage of net profits to charities supporting health and development programs for children, reflecting a commitment to social impact. They foster partnerships within the scientific community to advance vaccine programs.
- Feb 2025Grant (prize money)$275.1K
- Aug 2022Grant (prize money)$275.1K
- Sep 2019Grant (prize money)$224.2K
- Mar 2017Grant (prize money)$3M
#9
Series A · Portland, Oregon · founded 2011 · 15 employees$1.5Mraised▾
Innovative diabetes management solutions through a single, integrated device. They are dedicated to simplifying diabetes management and improving health outcomes for individuals requiring insulin. Their core innovation, a single device integrating continuous glucose monitoring and insulin delivery, aims to reduce the burden of managing diabetes with multiple devices. This technology offers continuous glucose monitoring, potentially lowering the risk of complications and improving overall well-being. They address a critical need in diabetes care by offering a streamlined solution. This has a social impact by improving the lives of those with diabetes.
- Oct 2025Series A$3.4M
- Mar 2025Series A$2.1M
- Sep 2023Series A$1.5M
- Sep 2019Grant (prize money)$1.8M
#10
Series A · Redmond, Oregon · founded 2016 · 2 employees$8Mraised▾
{}
- Apr 2025Series A$3M
- Jan 2025Series A$5M
#11
Series A · Eugene, Oregon · founded 2019 · 62 employees$3Mraised▾
InVivo Biosystems provider of animal models for in-vivo analytical services. The company's disease model includes C. elegance for transgenic services and Zebrafish for genome editing services. It also offers assay kit, reagents like PCR master mix, custom in-vivo testing and in-vivo toxicity testing.
- Feb 2025Grant (prize money)$2.8M
- Feb 2025Grant (prize money)$2.8M
- Jan 2025Grant (prize money)$464.7K
- Jan 2024Series A$3M
#12
Series B · Portland, Oregon · founded 2016 · 26 employees$4.7Mraised▾
Innovative women's health solutions for comfortable gynecological exams and procedures. This company is revolutionizing the gynecological exam experience with total solution products designed for patient comfort and clinician ease. They offer a range of modern speculums, including reusable and single-use options, along with accessories like tissue retraction sheaths and portable exam lights. Their products prioritize patient comfort with features like quiet operation, narrow designs, and temperature-neutral materials. They focus on innovation in women's health, offering solutions that improve clinician efficiency and enhance the overall patient experience. The company's products are available for purchase through their online store, with options to log in, view cart, and check out. They also provide resources like instructions for use, product brochures, and information on their story and mission. They are committed to empowering the GYN experience through design and innovation.
- Feb 2025Series B$20M
- Jan 2020Series A$4.7M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in Oregon is moving
A read on the academic research around Biotechnology in Oregon — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 42 papers.
Oregon State University leads Oregon's biotechnology research (42 papers, stance +0.47).
- Oregon State University20
- Oregon Health & Science University18
- University of Oregon3
- Oregon National Primate Research Center3
- Oregon Clinic1
- Population3
- Transcription factor2
- Gene2
- Genetic diversity2
- Neuroprotection1
- Metagenomics2
- Trabecular meshwork2
- Cathelicidin1
- TLR21
- Vitamin D and neurology1
- Feedlot1
- Beef cattle1
- Trace mineral1
- Animal health1
- Feed conversion ratio1
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.